Contrast media-associated nephrotoxicity

Current Opinion in Nephrology and Hypertension

Volumn 5, Issue 2, 1996, Pages 127-133

  Rudnick, Michael R ^a   Berns, Jeffrey S ^a   Cohen, Raphael M ^a   Goldfarb, Stanley ^a  

^a GRADUATE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CONTRAST MEDIUM; FUROSEMIDE; MANNITOL; THEOPHYLLINE; VASOACTIVE AGENT;

ACUTE KIDNEY FAILURE; DIABETES MELLITUS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UREMIA;

CONTRAST MEDIA; HUMANS; KIDNEY DISEASES;

EID: 0029905475     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199603000-00005     Document Type: Review

References (83)

1. Hou SH, Bushinsky DA, Wish JB, Cohen JJ Harrington JT: Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983, 74:243-248.
2. Coggins CH, Fang LS-T: Acute renal failure with antibiotics, anesthetic agents, and radiographic contrast agents. In Acute renal failure, edn 2. Edited by Brenner BM, Lazurus JM. New York: Churchill Livingstone; 1988:295-352.
3. Berns AS: Nephrotoxicity of contrast media. Kidney Int 1989, 36:730-740.
4. Bakris GL: Pathogenesis and therapeutic aspects of radiocontrast-induced renal dysfunction. In Toxicology of the kidney, edn 2. Edited by Hook JB, Goldstein RS. New York: Raven Press, Ltd; 1993: 361-386.
5. Barrett BJ: Contrast nephrotoxicity. J Am Soc Nephrol 1994, 5:125-137. An excellent up to date critical review of pathophysiologic and clinical features of contrast media nephrotoxicity.
6. Idée JM, Beaufils H, Bonnemain B: Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention. Fundam Clin Pharmacol 1994, 8:193-206.
7. Heyman SN, Rosen S, Brezis M: Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 1994, 2:153-157. An outstanding review of experimental studies of contrast nephrotoxicity which unifies different observations into a single hypothesis on pathogenesis and postulates possible clinical correlations.
8. Rudnick MR, Berns JS, Cohen RM, Goldfarb S: Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism - a critical review. Am J Kidney Dis 1994, 24:713-727. A recent clinical review of contrast nephrotoxicity which includes a review of the more serious complication of intra-arterial radiological studies i.e. atheroembolism.
9. Katzberg RW, Morris TW, Burgener FA, Kamm D, Fischer HW: Renal renin and hemodynamic responses to selective renal artery catheterization and angiography. Invest Radiol 1977, 12:381-388.
10. Bakris GL, Burnett JC Jr: A role for calcium in radiocontrast-induced reductions in renal hemodynamics. Kidney Int 1985, 27:465-468.
11. Caldicott WJH, Hollenberg NK, Abrams HL: Characteristics of response of renal vascular bed to contrast media. Evidence of vasoconstriction induced by renin-angiotensin system. Invest Radiol 1970, 5:539-547.
12. Heyman SN, Brezis M, Reubinoff CA, Greenfield Z, Lechene C, Epstein FH, Rosen S: Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988, 82:401-412.
13. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991, 40:632-642.
14. Vari RC, Natarajan LA, Whitescarver SA, Jackson BA, Ott CE: Induction, prevention and mechanisms of contrast media-induced acute renal failure. Kidney Int 1988, 33:699-707.
15. Workman RJ, Shaff MI, Jackson RV, Diggs J, Frazer MG, Briscoe C: Relationship of renal hemodynamics and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog. Invest Radiol 1983, 18:160-166.
16. Deray G, Martinez F, Cacoub P, Barmelou B, Jacobs C: A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 1990, 10:316-322.
17. Rubinger D, Hochman O, Popovitzer MM: Contrast medium (CM) induced renal failure in experimental diabetes mellitus (DM). The role of endogenous prostaglandins (PG) [Abstract]. J Am Soc Nephrol 1995, 6:1003.
18. Cantley LG, Spokes K, Clark B, McMahon EG, Carer J, Epstein FH: Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993, 44:1217-1223.
19. Arend LJ, Bakris GL, Burnett JC Jr, Megerian C, Spielman WS: Role of intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 1987, 110:406-411.
20. •] suggest that theophylline, an adenosine antagonist, may be of value in preventing contrast nephrotoxicity in humans. Additional studies using a large number of high-risk patients will be needed to clarify if theophylline is an effective prophylactic agent.
21. •].
22. Arakawa K, Suzuki H, Naitoh M, Matsumoto A, Ichihara A, Oka K, Saruta T: Adenosine A-1 receptor antagonist, KW3902, completely prevents non-ionic radiocontrast-induced renal insufficiency (RCIN) in conscious dogs with renal insufficiency [Abstract]. J Am Soc Nephrol 1994, 5:916.
23. Erley CM, Burgert K, Langanke J, Osswald H, Risler T: Prevention of radiocontrast-induced nephropathy (RCIN) by adenosine antagonism [Abstract], J Am Soc Nephrol 1995, 6:162.
24. Okumura M, Miura K, Yamashita Y, Yukimura T, Yamamoto K: Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs. J Pharmacol Exp Ther 1992, 260:1262-1267.
25. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S: Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J Clin Invest 1991, 88:390-395.
26. Touati C, Idée JM, Deray G, Santus R, Balut C, Beaufils H, Jouanneau C, Bourbouze R, Doucet D, Bonnemain B: Modulation of the renal effects of contrast media by endothelium-derived nitric oxide in the rat Invest Radiol 1993, 28:814-820.
27. Erley CM, Burgert K, Langanke J, Osswald H, Risler T: A novel animal model of radiocontrast-induced nephropathy (RCIN) [Abstract]. J Am Soc Nephrol 1995, 6:462.
28. Margulies KB, Hildebrand FL, Heublein DM, Burnett JC Jr: Radio-contrast increases plasma and urinary endothelin. J Am Soc Nephrol 1991, 2:1041-1045.
29. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, Epstein FH: Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992, 3:58-65.
30. Kubo M, Hirakata H, Okuda S, Fujishima M: Increase in urinary endothelin excretion after radiocontrast infusion (RC) in patients with chronic renal failure (CRF) [Abstract]. J Am Soc Nephrol 1995, 6:1000.
31. Heyman SN, Clark, BA, Cantley L, Spokes K, Rosen S, Brezis M, Epstein FH: Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy. Invest Radiol 1993, 28:313-318.
32. Brooks DP, DePalma PD: Blockade of radiocontrast-induced renal vasoconstriction by endothelin receptor antagonist, SB 209670 [Abstract]. J Am Soc Nephrol 1994, 5:918.
33. Oldroyd S, Slee S-J, Haylor J, Morcos SK, Wilson C. Role for endothelin in the renal responses to radiocontrast media in the rat Clin Sci 1994, 87: 427-434.
34. Oldroyd SD, Haylor JL, Morcos SK; The acute effect of ioversol on kidney function: role of endothelin. Eur J Radiol 1995, 19:91-95.
35. A receptor blockade in radiocontrast-induced nephropathy in the rat [Abstract]. J Am Soc Nephrol 1995, 6:667.
36. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr: Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 1990, 258:F115-F120.
37. Parvez Z, Rahman MA, Moncada R: Contrast media-induced lipid peroxidation in the rat kidney. Invest Radiol 1989, 24:697-702.
38. Yoshioka T, Fogo A, Beckman JK: Reduced activity of antioxidant enzyme underlies contrast media-induced renal injury in volume depletion. Kidney Int 1992, 41:1008-1015.
39. Moreau J-F, Droz D, Noel L-E, Leibowitch J, Jungers P, Michel J-R: Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 1980, 15:S54-S60.
40. Deray G, Dubois M, Martinez F, Baumelou B, Beaufils H, Bourbouze R, Baumelou A, Jacobs C: Renal effects of radiocontrast agents in rats: a new model of acute renal failure. Am J Nephrol 1990, 10: 507-513.
41. Battenfeld R, Khater AER, Drommer W, Guenzel P, Kaup FJ: Ioxaglate-induced light and electron microscopic alternations in the renal proximal tubular epithelium of rats. Invest Radiol 1991, 26:35-39.
42. Golman K, Almen T: Contrast media-induced nephrotoxicity. Survey and present state. Invest Radiol 1985, 20:S92-S97.
43. Humes HD, Hunt DA, White MD: Direct toxic effect of the radiocontrast agent diatrizoate on proximal tubule cells. Am J Physiol 1987, 252:F246-F255.
44. Messana JM, Cieslinski DA, Nguyen VD, Humes HD: Comparison of the toxicity of the radiocontrast agents iopamidol and diatrizoate to rabbit renal proximal tubule cells in vitro. J Pharmacol Exp Ther 1988, 244:1139-1144.
45. Andersen K-J, Christensen El, Vik H: Effects of iodinated x-ray contrast media on renal epithelial cells in culture. Invest Radiol 1994, 29:955-962.
46. Love L, Johnson MS, Bresler ME, Nelson JE, Olson MC, Flisak ME: The persistent computed tomography nephrogram: its significance in the diagnosis of contrast-associated nephrotoxicity. Br J Radiol 1994, 67:951-957.
47. Levy E, Viscoli CM, Horwitz RI: Unexpected high mortality in contrast nephrotoxicity [Abstract]. J Am Soc Nephrol 1993, 4:319.
48. Levy E, Viscoli CM, Horwitz RI: High mortality in contrast-associated renal failure is not explained by comorbidity [Abstract]. J Am Soc Nephrol 1994, 5:400.
49. Perneger TV, Whelton PK, Klag MJ: Exposure to radiocontrast media and risk of end-state renal disease [Abstract]. J Am Soc Nephrol 1993, 4:256.
50. Cramer BC, Parfrey PS, Hutchinson TA, Baran D, Melanson DM, Ethier RE, Seely JF: Renal function following infusion of radiologic contrast material: a prospective controlled study. Arch Intern Med 1985, 145:87-89.
51. Moore RD, Steinberg EP, Powe NR, White RI Jr, Brinker JA, Fishman EK, Zinreich SJ, Smith CR: Frequency and determinants of adverse reactions induced by high-osmolality contrast media. Radiology 1989, 170:727-732.
52. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, Bashore TM: Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent N Engl J Med 1989, 320:149-153.
53. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramiti N, Friedman AC, Lautin JL, Braha S, Kadish EG, Sprayregen S, Belizon I: Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media. Am J Roentgenol 1991, 157:59-65.
54. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, O'Dea F, Stone E, Reddy R, McManamon PJ: Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992, 41:1274-1279.
55. Moore RD, Steinberg EP, Powe NR, Brinker JA, Fishman EK, Graziano S, Gopalan R: Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992, 182:649-655.
56. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995, 47:254-261. A comparative study of the risk of contrast nephrotoxicity between HOCM and LOCM in the largest number of 'high-risk' patients evaluated to date. The findings clearly demonstrate a reduced incidence of contrast nephrotoxicity in azotemic patients with LOCM.
57. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989, 320:143-149.
58. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG, Sprayregen S, Belizon I: Radiocontrast-associated renal dysfunction: incidence and risk factors. Am J Roentgenol 1991, 157:49-58.
59. Harris KG, Smith TP, Cragg AH, Lemke JH: Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. Radiology 1991, 179:849-852.
60. Taliercio CP, Vlietstra RE, Ilstrup DM, Burnett JC, Menke KK, Stensrud SL, Holmes DR Jr: A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac anglography. J Am Coll Cardiol 1991, 17:384-390.
61. Weisberg LS, Kurnik PB, Kurnik BRC: Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994, 45:259-265. A provocative study which suggests that azotemic diabetics, as compared with azotemic non-diabetics, have an exaggerated renovascular reactivity which may predispose them to an increased risk of contrast nephrotoxicity, and an absent prophylactic benefit to vasodilatory drugs.
62. Harkonen S, Kjellstrand CM: Exacerbation of diabetic renal failure following intravenous pyelography. Am J Med 1977, 63:939-946.
63. Manske CL, Sprafka JM, Strony JT, Wang Y: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990, 89:615-620.
64. Shafi T, Chou S-Y, Porush JG, Shapiro WB: Infusion intravenous pyelography and renal function: effects in patients with chronic renal insufficiency. Arch Intern Med 1978, 138:1218-1221.
65. Cigarroa RG, Lange RA, Williams RH, Hillis LD: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989, 86:649-652.
66. McClennan BL, Stolberg HO: Intravascular contrast media. Ionic versus nonionic: current status. Radiol Clin North Am 1991, 29:437-454.
67. •].
68. Idée J-M, Santus R, Beaufils H, Huntsman AM, Bourbouze R, Koeltz B, Jovanneau C, Bonnemain B: Comparative effects of low- and high-osmolar contrast media on the renal function during early degenerative gentamicin-induced nephropathy in rats. Am J Nephrol 1995, 15:66-74.
69. Deray G, Bellin M-F, Boulechfar H, Baumelou B, Koskas F, Baumelou A, Greitet J, Jacobs C: Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: comparison of low- and high-osmolar contrast agents. Am J Nephrol 1991, 11:309-312.
70. Gomes AS, Lois JF, Baker JD, McGlade CT, Bunnell DH, Hartzman S: Acute renal dysfunction in high-risk patients after angiography: comparison of ionic and nonionic contrast media. Radiology 1989, 170:65-68.
71. Barrett BJ, Carlisle EJ: Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993, 188:171-178.
72. Harnish PP, Fountaine H, Ebrahimi R: Iodixanol. Experience in 1,259 patients in the United States. Invest Radiol 1994, 29:8236-8237.
73. •] suggest that 2nd generation LOCM, non-ionic dimers iso-osmolar with plasma, are less nephrotoxic in experimental models than either HOCM or non-ionic monomers. Whether these newer iso-osmolar contrast agents are less nephrotoxic in humans is currently unknown.
74. Rudnick MR, Goldfarb S, Murphy MJ: Mannitol and other prophylactic regimens in contrast media-induced acute renal failure. Coronary Artery Dis 1991, 2:1047-1052.
75. Anto HR, Chou S-Y, Porush JC, Shapiro WB: Infusion intravenous pyelography and renal function: effects of hypertonic mannitol in patients with chronic renal insufficiency. Arch Intern Med 1981, 141:1652-1656.
76. Solomon R, Werner C, Mann D, D'Elia J, Silver P: Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994, 331:1416-1420. This study demonstrates that in 'high-risk' patients saline hydration alone provides better protection against contrast nephrotoxicity than saline hydration with mannitol or furosemide. This is the first study which used a prospective randomized protocol to compare these three widely used prophylactic strategies. It remains unknown whether shorter periods of saline hydration would be equally effective in this era of cost containment.
77. Ghandour F, Larranaga J, Manon A, Papp MA, Pawar R, Rahman M, Weigel K, Smith MC: The effect of mannitol (M) on the development of contrast-associated nephropathy (CAN) in patients with chronic renal insufficiency (CRI) [Abstract]. J Am Soc Nephrol 1995, 6:464.
78. Weinstein J-M, Heyman S, Brezis M: Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 1992, 62:413-415.
79. Kremer D, Wood L, Bennett W, Porter G: Short and long term effect of calcium channel blockers (CCB) on contrast nephropathy (CN) in dogs [Abstract]. J Am Soc Nephrol 1994, 5:925.
80. Fenves AZ, Allgren RL for the Auriculin Anaritide ARF Study Group: Radiocontrast dye-induced acute tubular necrosis (ATN): atrial natriuretic peptide (ANP) versus placebo [Abstract]. J Am Soc Nephrol 1995, 6:463.
81. Waaler A, Svalend M, Fouchald P, Jakobsen JA, Kolmannskog F, Berg KJ: Elimination of iohexol, a low osmolar contrast medium by hemodialysis in patients with chronic renal failure. Nephron 1990, 56:81-85.
82. Moon SS, Bäak SE, Kurkus J, Nilsson-Ehle P: Hemodialysis for elimination of the nonionic contrast medium iohexol after angioplasty in patients with impaired renal function. Nephron 1995, 70:430-437.
83. Lehnert T, Gondolf K, Schäffner T Schollmeyer P, Keller E: Effect of hemodialysis after contrast media application in adults with renal insufficiency [Abstract]. J Am Soc Nephrol 1995, 6:469.